Robertn Fried News Today

The latest news on all things 4k Ultra HD, Blu-ray and Gear

The latest news on all things 4k Ultra HD, Blu-ray and Gear

ChromaDex (NASDAQ:CDXC – Get Rating) had its price objective cut by stock analysts at HC Wainwright from $8.00 to $7.00 in a note issued to investors on Tuesday, The Fly reports. HC Wainwright’s price target indicates a potential upside of 266.49% from the stock’s current price. CDXC has been the topic of several other research […]

Brokerages expect ChromaDex Co. (NASDAQ:CDXC – Get Rating) to announce sales of $18.87 million for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for ChromaDex’s earnings, with the highest sales estimate coming in at $21.00 million and the lowest estimate coming in at $16.07 million. ChromaDex posted sales of $17.70 […]

Zacks Investment Research upgraded shares of ChromaDex (NASDAQ:CDXC – Get Rating) from a sell rating to a hold rating in a research report report published on Wednesday, Zacks.com reports. According to Zacks, “ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food […]

ChromaDex Co. (NASDAQ:CDXC – Get Rating) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 3,440,000 shares, an increase of 27.4% from the April 15th total of 2,700,000 shares. Currently, 8.9% of the company’s stock are short sold. Based on an average daily […]

Equities research analysts expect that ChromaDex Co. (NASDAQ:CDXC – Get Rating) will announce earnings per share of ($0.09) for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for ChromaDex’s earnings, with the highest EPS estimate coming in at ($0.07) and the lowest estimate coming in at ($0.12). ChromaDex reported earnings per […]

Zacks Investment Research downgraded shares of ChromaDex (NASDAQ:CDXC – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Monday, Zacks.com reports. According to Zacks, “ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, […]

ChromaDex (NASDAQ:CDXC – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and […]

Wall Street brokerages expect ChromaDex Co. (NASDAQ:CDXC – Get Rating) to report $17.42 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for ChromaDex’s earnings, with the lowest sales estimate coming in at $15.73 million and the highest estimate coming in at $19.00 million. ChromaDex posted sales of $14.68 […]